BRCA1, BRCA2 and their possible function in DNA damage response

por Kote-Jarai, Z, Eeles, R A
Publicado 1999

Management of Breast Cancer in BRCA1/2 Mutation Carriers

por Eeles, R. A., Camplejohn, R., Peacock, J., McMillan, T.
Publicado 1999

Non-Hodgkin's lymphoma presenting with extradural spinal cord compression: functional outcome and survival.

por Eeles, R. A., O'Brien, P., Horwich, A., Brada, M.
Publicado 1991

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers

por Kadouri, L, Kote-Jarai, Z, Hubert, A, Baras, M, Abeliovich, D, Hamburger, T, Peretz, T, Eeles, R A
Publicado 2008

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

por Kadouri, L, Kote-Jarai, Z, Hubert, A, Durocher, F, Abeliovich, D, Glaser, B, Hamburger, T, Eeles, R A, Peretz, T
Publicado 2004

Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer

por Moynihan, C., Bancroft, E.K., Mitra, A., Ardern‐Jones, A., Castro, E., Page, E.C., Eeles, R.A.
Publicado 2017

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

por Kadouri, L, Easton, D F, Edwards, S, Hubert, A, Kote-Jarai, Z, Glaser, B, Durocher, F, Abeliovich, D, Peretz, T, Eeles, R A
Publicado 2001

Head and neck sarcomas: prognostic factors and implications for treatment.

por Eeles, R. A., Fisher, C., A'Hern, R. P., Robinson, M., Rhys-Evans, P., Henk, J. M., Archer, D., Harmer, C. L.
Publicado 1993

No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British...

por Edwards, S. M., Dearnaley, D. P., Ardern-Jones, A., Hamoudi, R. A., Easton, D. F., Ford, D., Shearer, R., Dowe, A., Eeles, R. A.
Publicado 1997

The value of rapid functional assays of germline p53 status in LFS and LFL families

por Camplejohn, R S, Sodha, N, Gilchrist, R, Lomax, M E, Duddy, P M, Miner, C, Alarcon-Gonzalez, P, Barnes, D M, Eeles, R A
Publicado 2000

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours

por Sodha, N, Bullock, S, Taylor, R, Mitchell, G, Guertl-Lackner, B, Williams, R D, Bevan, S, Bishop, K, McGuire, S, Houlston, R S, Eeles, R A
Publicado 2002

Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators...

por Dunsmuir, W. D., Edwards, S. M., Lakhani, S. R., Young, M., Corbishley, C., Kirby, R. S., Dearnaley, D. P., Dowe, A., Ardern-Jones, A., Kelly, J., Eeles, R. A.
Publicado 1998

Apoptosis, ageing and cancer susceptibility

por Camplejohn, R S, Gilchrist, R, Easton, D, McKenzie-Edwards, E, Barnes, D M, Eccles, D M, Ardern-Jones, A, Hodgson, S V, Duddy, P M, Eeles, R A
Publicado 2003

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease

por Meitz, J C, Edwards, S M, Easton, D F, Murkin, A, Ardern-Jones, A, Jackson, R A, Williams, S, Dearnaley, D P, Stratton, M R, Houlston, R S, Eeles, R A
Publicado 2002

ATM polymorphisms as risk factors for prostate cancer development

por Angèle, S, Falconer, A, Edwards, S M, Dörk, T, Bremer, M, Moullan, N, Chapot, B, Muir, K, Houlston, R, Norman, A R, Bullock, S, Hope, Q, Meitz, J, Dearnaley, D, Dowe, A, Southgate, C, Ardern-Jones, A, Easton, D F, Eeles, R A, Hall, J
Publicado 2004

Hand pattern indicates prostate cancer risk

por Rahman, A A, Lophatananon, A, Stewart-Brown, S, Harriss, D, Anderson, J, Parker, T, Easton, D, Kote-Jarai, Z, Pocock, R, Dearnaley, D, Guy, M, O'Brien, L, Wilkinson, R A, Hall, A L, Sawyer, E, Page, E, Liu, J-F, Eeles, R A, Muir, K
Publicado 2011

Reply: ‘Hand pattern indicates risk of prostate cancer’

por Rahman, A A, Lophatananon, A, Stewart-Brown, S, Harriss, D, Anderson, J, Parker, T, Easton, D, Kote-Jarai, Z, Pocock, R, Dearnaley, D, Guy, M, O'Brien, L, Wilkinson, R A, Hall, A L, Sawyer, E, Page, E, Liu, J-F, Eeles, R A, Muir, K-R
Publicado 2011

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis

por Edwards, S M, Evans, D G R, Hope, Q, Norman, A R, Barbachano, Y, Bullock, S, Kote-Jarai, Z, Meitz, J, Falconer, A, Osin, P, Fisher, C, Guy, M, Jhavar, S G, Hall, A L, O'Brien, L T, Gehr-Swain, B N, Wilkinson, R A, Forrest, M S, Dearnaley, D P, Ardern-Jones, A T, Page, E C, Easton, D F, Eeles, R A
Publicado 2010

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript

por Kote-Jarai, Z., Amin Al Olama, A., Leongamornlert, D., Tymrakiewicz, M., Saunders, E., Guy, M., Giles, G. G., Severi, G., Southey, M., Hopper, J. L., Sit, K. C., Harris, J. M., Batra, J., Spurdle, A. B., Clements, J. A., Hamdy, F., Neal, D., Donovan, J., Muir, K., Pharoah, P. D. P., Chanock, S. J., Brown, N., Benlloch, S., Castro, E., Mahmud, N., O’Brien, L., Hall, A., Sawyer, E., Wilkinson, R., Easton, D. F., Eeles, R. A.
Publicado 2011

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

por Gillessen, S., Omlin, A., Attard, G., de Bono, J. S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R., Soule, H. R., Akaza, H., Beer, T. M., Beltran, H., Chinnaiyan, A. M., Daugaard, G., Davis, I. D., De Santis, M., Drake, C. G., Eeles, R. A., Fanti, S., Gleave, M. E., Heidenreich, A., Hussain, M., James, N. D., Lecouvet, F. E., Logothetis, C. J., Mastris, K., Nilsson, S., Oh, W. K., Olmos, D., Padhani, A. R., Parker, C., Rubin, M. A., Schalken, J. A., Scher, H. I., Sella, A., Shore, N. D., Small, E. J., Sternberg, C. N., Suzuki, H., Sweeney, C. J., Tannock, I. F., Tombal, B.
Publicado 2015